Difference between revisions of "Cyclophosphamide (Cytoxan)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
Line 5: Line 5:
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://reference.medscape.com/drug/cytoxan-cyclophosphamide-342214 Medscape],[http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://reference.medscape.com/drug/cytoxan-cyclophosphamide-342214 Medscape],[http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 +
 +
==Diseases for which it is used==
 +
*[[Acute lymphocytic leukemia]]
 +
*[[Aggressive Non-Hodgkin lymphoma]]
 +
*[[Bladder cancer]]
 +
*[[Bone cancer]]
 +
*[[Breast cancer]]
 +
*[[Central nervous system (CNS) cancer]]
 +
*[[Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL)]]
 +
*[[Follicular lymphoma]]
 +
*[[HIV-associated lymphoma]]
 +
*[[Hodgkin lymphoma]]
 +
*[[Hodgkin lymphoma, nodular lymphocyte-predominant]]
 +
*[[Light-chain (AL) amyloidosis]]
 +
*[[Mantle cell lymphoma]]
 +
*[[Multiple myeloma]]
 +
*[[Neuroendocrine tumors]]
 +
*[[Prostate cancer]]
 +
*[[Small cell lung cancer]]
 +
*[[Thymoma]]
 +
*[[Transplant conditioning regimens]]
  
 
==Patient drug information==
 
==Patient drug information==
 
*[http://chemocare.com/chemotherapy/drug-info/cyclophosphamide.aspx Cyclophosphamide (Cytoxan) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/cyclophosphamide.aspx Cyclophosphamide (Cytoxan) patient drug information (Chemocare)]</ref>
 
*[http://chemocare.com/chemotherapy/drug-info/cyclophosphamide.aspx Cyclophosphamide (Cytoxan) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/cyclophosphamide.aspx Cyclophosphamide (Cytoxan) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/cyclophosphamide-patient-drug-information Cyclophosphamide (Cytoxan) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/cyclophosphamide-patient-drug-information Cyclophosphamide (Cytoxan) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/cyclophosphamide-patient-drug-information Cyclophosphamide (Cytoxan) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/cyclophosphamide-patient-drug-information Cyclophosphamide (Cytoxan) patient drug information (UpToDate)]</ref>
 +
 +
==History of changes in FDA indication==
 +
*11/16/1959: initial FDA approval
  
 
==Also known as==
 
==Also known as==
Line 99: Line 123:
 
[[Category:Thymoma medications]]
 
[[Category:Thymoma medications]]
 
[[Category:Transplant medications]]
 
[[Category:Transplant medications]]
 +
 +
[[Category:Drugs FDA approved in 1959]]

Revision as of 15:28, 23 October 2014

General information

Class/mechanism: Alkylating agent; transformed primarily in the liver to active metabolites which alkylate and crosslink DNA.[1][2]
Route: IV, PO
Extravasation: irritant, n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape,UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

History of changes in FDA indication

  • 11/16/1959: initial FDA approval

Also known as

Synonyms
Alkyloxan Biodoxan Carloxan Ciclofosfamida Ciclofosfamida Filaxis Ciclofosfamida Martian Ciclokebir Cyclam
Cycloblastin Cycloblastine Cyclo Cell Cycloferon Cyclomide Cyclophar Cyclophospham Cyclophosphamid
cyclophosphamide monohydrate Cyclophosphamid Farmos Cyclophosphan Cyclophosphan Lens Cyclostin Cycloxan Cycram Cydoxan
Cyklofosfamid Cytophosphan Cytoxan Cytoxan Lyophilized Endoxan Endoxan-N Endoxana Endoxan Asta
Formitex Genoxal Genuxal Hidrofosmin Ledoxan Ledoxina Lyophilized Cytoxan Neosar
Oncomide Oncophos Procytox Revimmune Sendoxan Syklofosfamid Trav Cyclophosphamide Tymtran
Zycram

References

  1. ↑ 1.0 1.1 Cyclophosphamide (Cytoxan) package insert
  2. ↑ Cyclophosphamide (Cytoxan) package insert (locally hosted backup)
  3. ↑ Cyclophosphamide (Cytoxan) patient drug information (Chemocare)
  4. ↑ Cyclophosphamide (Cytoxan) patient drug information (UpToDate)
Retrieved from "https://hemonc.org/w/index.php?title=Cyclophosphamide_(Cytoxan)&oldid=5160"